Doximity, Inc. (DOCS) Stock Analysis
Recovery setup · Temp Headwind edge
Healthcare · Health Information Services
Sell if holding. Momentum 3.6/10 is below the 5.0 floor at $24.16 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Leverage penalty (D/E 1.1): -0.5; Weak growth.
Doximity is the leading digital platform for U.S. medical professionals with over 2 million registered members including 80%+ of U.S. physicians. Revenue from pharmaceutical manufacturers and health systems paying for Marketing, Hiring, and Workflow Solutions grew 20% in fiscal... Read more
Sell if holding. Momentum 3.6/10 is below the 5.0 floor at $24.16 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Leverage penalty (D/E 1.1): -0.5; Weak growth. Chart setup: Death cross but MACD improving, RSI 69. Score 5.6/10, moderate confidence.
Passes 5/8 gates (favorable risk/reward ratio, clean insider activity, no SEC red flags, news events none recent, semi cycle peak clear). Fails on weak momentum and death cross (50MA < 200MA). Suitability: aggressive.
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- MEDIUMCustomerpharmaceutical manufacturer customers10-K Item 1A: 'We do not typically enter into long-term contracts with our pharmaceutical manufacturer customers, who represent a significant portion of our revenue'
Material Events(8-K, last 90d)
- 2026-04-17Item 5.02HIGHCFO Anna Bryson resignation accepted April 13, 2026 (had been on medical leave since February 3, 2026). Siddharth Sitaram continues as interim CFO. Company conducting search; no permanent successor named.SEC filing →
- 2026-02-05Item 5.02HIGHCFO Anna Bryson placed on medical leave effective February 3, 2026. Siddharth Sitaram (Chief Accounting Officer) appointed interim principal financial officer. No permanent successor named.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer
Rating Breakdown
3 floor-breakers
Growth below the gate floor. Component breakdown shows what dragged the score down.static
Technicals below the gate floor. Component breakdown shows what dragged the score down.static
Momentum below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Momentum 3.6/10 is below the 5.0 floor at $24.16 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Leverage penalty (D/E 1.1): -0.5; Weak growth. Chart setup: Death cross but MACD improving, RSI 69. Prior stop was $22.45. Score 5.6/10, moderate confidence.
Take-profit target: $34.00 (+40.8% upside). Prior stop was $22.45. Stop-loss: $22.45.
Leverage penalty (D/E 1.1): -0.5; Weak growth; Negative momentum.
Doximity, Inc. trades at a P/E of 20.3 (forward 14.9). TrendMatrix value score: 7.1/10. Verdict: Sell.
30 analysts cover DOCS with a consensus score of 4.1/5. Average price target: $38.
What does Doximity, Inc. do?Doximity is the leading digital platform for U.S. medical professionals with over 2 million registered members...
Doximity is the leading digital platform for U.S. medical professionals with over 2 million registered members including 80%+ of U.S. physicians. Revenue from pharmaceutical manufacturers and health systems paying for Marketing, Hiring, and Workflow Solutions grew 20% in fiscal 2025. Network effects create a moat as member scale drives physician engagement and increases value to marketing customers.